This program is grounded in the pioneering research of Professor Shai Efrati (Tel Aviv University / Sagol Center for Hyperbaric Medicine) and the latest advances in neuroplasticity, pain modulation, and regenerative medicine — applied in a structured, clinically sequenced 8-week protocol.

Clinical research has demonstrated that HBOT can produce measurable reductions in fibromyalgia pain scores, fatigue, and cognitive symptoms — outcomes linked to identifiable biological changes: improved brain metabolism, reduced neuroinflammation, enhanced mitochondrial function and the promotion of neuroplasticity in pain-regulating regions of the brain.

This is not pain management. It is biological recalibration. 
By targeting the hypersensitised central nervous system directly — flooding the brain with oxygen, reducing neuroinflammation and stimulating neuroplastic change — the program aims to change the way the nervous system processes pain, rather than simply masking it.
The addition of cognitive stimulation and lifestyle medicine amplifies these effects, addressing the cognitive and metabolic dimensions of fibromyalgia that HBOT alone cannot fully reach. 

The result is a protocol that treats fibromyalgia as what it is: 
a complex neurological condition requiring a multi-layered, biologically grounded response.